A novel snake venom‐derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury

Conclusions and ImplicationsOur data indicate anfibatide is a safe GPIb antagonist that exerts a protective effect on cerebral ischaemia and reperfusion injury. Anfibatide is a promising candidate that could be beneficial for the treatment of ischaemic stroke.

Source: British Journal of Pharmacology - June 12, 2015 Category: Drugs & Pharmacology Authors: Ting‐Ting Li, Man‐Li Fan, Shi‐Xiang Hou, Xiao‐Yi Li, Devin M Barry, Hui Jin, Sheng‐Yong Luo, Feng Kong, Lit‐Fui Lau, Xiang‐Rong Dai, Guo‐Hui Zhang, Lan‐Lan Zhou Tags: RESEARCH PAPER Source Type: research